Bliss, an AI-driven platform for cosmetic enhancement, announced its $17.5 million seed funding round to grow the platform amid a rapidly evolving cosmetic procedure market estimated to climb to $200 billion in revenue within 10 years. Shine Capital led the financing, followed by Synchrony Ventures, Sheva Ventures, Point72 Ventures, and Cerca Partners.

Bliss is the first system of intelligence for cosmetic enhancement. By combining an AI-powered decision engine with intelligent matchmaking and 24/7 customer assistance, Bliss equips patients to make informed, confident decisions and gives surgeons the tools to serve their patients better while having more time to focus on performing procedures.